Carcinoid breast tumor
DOI:
https://doi.org/10.35954/SM1998.20.1.9Keywords:
Breast carcinoid, neuroendocrine neoplasia.Abstract
Carcinoid breast tumor is a rare, infrequent entity, whose clinical description was made by Cubilla and Woodruff in 1977. Its correct histogenetic interpretation is still under analysis, as well as its treatment.
The authors report two clinical cases of patients with breast carcinoid tumors, detailing the clinical presentation, histology and treatment.
Downloads
References
(1) PEARSE AGE. The cytochemestry and ultrastructure of polypeptide hormone producing cells of the APUD series and the embryologic and physiologic of the concept. J Histochem Cytochem 1969; 17: 303.
(2) VAN LAARHOUEN HA, GRATAMA S, WERELDSMA JC. Neuroendocrine carcinoid tumours of the breast. A variant of carcinoma with neuroendocrine differentiation. J Surg Oncol 1991; 46: 125-132.
(3) AZUMI N, SHIBUYA H, ISHIKURA M. Primary Prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen. An J Surg Pathol 1984; 8: 545-551.
(4) DELELLIS RA, DAYAL Y, WOLFE HJ. Carcinoid tumors. Changing concepts and new perspectives. Editorial. Am J Surg Pathol 1984; 8: 295-301.
(5) WILANDE E, EL-SALHY M, PITKANEN P. Histopathology of gastric carcinoids. A survey of 42 cases. Histophatology 1984; 8: 183-193.
(6) ALI MH, DAVIDSON A, AZZOPARDI JG. Composite gastric carcinoid and adenocarcinoma. Histopathology 1984; 8: 529-536.
(7) MOOI WJ, DEWAR A, SPRINGALL D, POLAK IM, ADDIS BI. Non small cell lung carcinoma with neuroendocrine features. A light microscopic, inmunohistochemical and ultrastructural study of 11 cases. Histopathology 1988; 13: 329-339.
(8) ULICH TR, KOLLIN M, LEWIN KJ. Composite gastric carcinoma. Arch Pathol Lab Med 1988; 112: 91-93.
(9) DAWSON IMP. Giffuse endocrine and neuroendocrine cell tumours. In Anthony PP, Mac Sween RNM (eds): "Recents advances in Histopathology". Vol. 12 New York: Churchill, Livingstone, 1984, 111-128.
(10) CUBILLA AL, WOODRUFF JM. Primary carcinoid tumor of the breast. A report of 8 patients. Am J Surg Pathol 1977; 1: 283-292.
(11) KANEKO H, HOJO H, ISHIKAWA S, YAMANOUCHI H, SUMIDA T. Norepinephrine producing tumours of bilateral breasts. Cancer 1978; 41: 2002-2007.
(12) FISCHER ER, PALEKAR AS, NSABP collaborators. Solid and mucinous varieties of so- called mammary carcinoid tumours. Am J Clin Pathol 1979; 72: 909-916.
(13) TAXY JB, TISCHLER AS, INSAKO SJ, BATTIFORA H. "Carcinoid" tumor of the breast. A variants of conventional breast cancer. Hum Pathol 1981; 12: 170-179.
(14) AZZOPARDI JG, MURETTO P, GOODEERIS P, EUSEBI U, LAUWERIJNS IM. "Carcinoid" tumors of the breast: the morphological spectrum of argyrophil carcinoma. Histopathology 1982; 6: 549- 569.
(15) CROSS AS, AZZOPARDI JG, KRAUSZ T, VAN NOORDEN S, POLAK JM. A morphological and inmunocytochemiscal study of a distinctive variant of ductal carcinoma in situ of the breast. Histopathology 1985; 9: 21-37.
(16) NESLAND JM, HOLM R, JOHANNESEN JV, GOULD VE. Neurone specific enolase inmunostaining in the diagnosis of the breast carcinoma with neuroendocrine differentiation. Its usefulness and limitations. J Pathol 1986; 148: 35-43.
(17) BUSSOLATI G, PAPO HIM, SAPINO A. Endocrine markers inorgyrophilic carcinoma of the breast. Am J Surg Pathol 1987; 11: 248-256.
(18) PEARSE AGE. Carcinoid of the breast-factor pigment? (Editorial). Am J Surg Pathol 1977; 1: 303-304.
(19) RODRIGUEZ R, GONZALEZ S, DEL CAMPO A, GARBINO C. Tumor carcinoide mucosecretante de mama. Observación Clínica. III Congreso Uruguayo de Oncología, Montevideo, diciembre de 1994. Archivos de Medicina Interna, Separata III Congreso Uruguayo de Oncología 1994 ; 15 Uruguay.
(20) MOERTEL CG. An adyssey in the land of small tumors. J Clin Oncol 1987; 5: 1503-1522.
(21) KLAPPENBACH RS, KURMAN RJ, SINLLAW CF, JAMES PL. Composite carcinoma-carcinoid tumors of the gastrointestinal tract. A morphological, histochemical and inmunocytochemical study. Am J Clin Pathol 1985; 84: 137-143.
(22) LINNOILA RI. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinoma. Am J Clin Pathol 1988; 90: 641-652.
(23) LLOYD RV, MERVAK M, SCHMIDT K, WARNES TFCS, WILSON BS. Inmunohistochemical detection of chromogranin and neurospecific enolase in pancreatic endocrine neoplasms. Am J Surg Pathol 1984; 8: 607-614.
(24) PAPOTTI M, MACRI L, FINI G, CAPELLA C, EUSEBI V, BUSSOLATI G. Neuroendocrine differentiation in carcinomas of the breast. A study of 11 cases. Semin Diagn Pathol 1989; 6: 174-188.
(25) LEGHA SS, VALDIVIESO M, NELSON RS. Chemotherapy for metastatic Carcinoid tumors with Interferon not as successfull as suggested. Cancer 1991; 67: 547-549.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
